Evidence map›Paper›PMID 34106995›Full record

ArticlePloS one2021

Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection.

Hannah M Edwards, Ruth Dixon, Celine Zegers de Beyl, Olivier Celhay, Mousumi Rahman, Moe Myint Oo, Thandar Lwin, Zaw Lin, Thiri San, Kay Thwe Han and 10 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Serology reveals comparable patterns in the transmission intensities ofFrontiers in cellular and infection microbiology · 2025
    Article
  5. Article
  6. Article
  7. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  8. Naturally acquired antibody response toFrontiers in cellular and infection microbiology · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Epidemiological characteristics ofFrontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hannah M EdwardsMalaria Consortium, Bangkok, Thailand.
Ruth DixonMalaria Consortium, Yangon, Myanmar.
Celine Zegers de BeylMalaria Consortium, London, United Kingdom.
Olivier CelhayMalaria Consortium, Bangkok, Thailand.ORCID 0000-0002-2971-9110
Mousumi RahmanMalaria Consortium, Yangon, Myanmar.
Moe Myint OoMalaria Consortium, Yangon, Myanmar.
Thandar LwinMinistry of Health and Sports, Yangon, Myanmar.
Zaw LinMinistry of Health and Sports, Yangon, Myanmar.
Thiri SanMinistry of Health and Sports, Yangon, Myanmar.
Kay Thwe HanParasitology Research Division, Department of Medical Research, Yangon, Myanmar.
Myaing Myaing NyuntUniversity of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Christopher PloweUniversity of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Gillian StresmanFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-6897-5459
Tom HallFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-9001-6684
Chris DrakeleyFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Prudence HamadeMalaria Consortium, London, United Kingdom.
Siddhi AryalMalaria Consortium, Bangkok, Thailand.
Arantxa Roca-FeltrerMalaria Consortium, London, United Kingdom.ORCID 0000-0002-7317-7101
Thaung HlaingMinistry of Health and Sports, Yangon, Myanmar.
Aung ThiMinistry of Health and Sports, Yangon, Myanmar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria incidence in Myanmar has significantly reduced over recent years, however, completeness and timeliness of incidence data remain a challenge. The first ever nationwide malaria infection and seroprevalence survey was conducted in Myanmar in 2015 to better understand malaria epidemiology and highlight gaps in Annual Parasite Index (API) data. The survey was a cross-sectional two-stage stratified cluster-randomised household survey conducted from July-October 2015. Blood samples were collected from household members for ultra-sensitive PCR and serology testing for P. falciparum and P. vivax. Data was gathered on demography and a priori risk factors of participants. Data was analysed nationally and within each of four domains defined by API data. Prevalence and seroprevalence of malaria were 0.74% and 16.01% nationwide, respectively. Prevalent infection was primarily asymptomatic P. vivax, while P. falciparum was predominant in serology. There was large heterogeneity between villages and by domain. At the township level, API showed moderate correlation with P. falciparum seroprevalence. Risk factors for infection included socioeconomic status, domain, and household ownership of nets. Three K13 P. falciparum mutants were found in highly prevalent villages. There results highlight high heterogeneity of both P. falciparum and P. vivax transmission between villages, accentuated by a large hidden reservoir of asymptomatic P. vivax infection not captured by incidence data, and representing challenges for malaria elimination. Village-level surveillance and stratification to guide interventions to suit local context and targeting of transmission foci with evidence of drug resistance would aid elimination efforts.

Indexed as

AdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansIncidenceMalaria, FalciparumMalaria, VivaxMaleMyanmarPlasmodium falciparumPlasmodium vivaxPrevalenceSeroepidemiologic Studies

Identifiers

PMID34106995
PMCPMC8189444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.